Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000553049 | SCV000622749 | uncertain significance | Ataxia-telangiectasia syndrome | 2023-03-30 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 453685). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The threonine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. This missense change has been observed in individual(s) with ATM-related conditions (PMID: 35047863). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces methionine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 2482 of the ATM protein (p.Met2482Thr). |
Ambry Genetics | RCV000562572 | SCV000672634 | uncertain significance | Hereditary cancer-predisposing syndrome | 2022-07-25 | criteria provided, single submitter | clinical testing | The p.M2482T variant (also known as c.7445T>C), located in coding exon 49 of the ATM gene, results from a T to C substitution at nucleotide position 7445. The methionine at codon 2482 is replaced by threonine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000779799 | SCV000916603 | uncertain significance | not specified | 2018-10-26 | criteria provided, single submitter | clinical testing | Variant summary: ATM c.7445T>C (p.Met2482Thr) results in a non-conservative amino acid change located in the PIK-related kinase, FAT domain (IPR003151) of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant was absent in 246004 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.7445T>C in individuals affected with Ataxia-Telangiectasia and no experimental evidence demonstrating its impact on protein function have been reported. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and both classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. |
Gene |
RCV003148773 | SCV003837361 | uncertain significance | not provided | 2022-08-30 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 23532176, 35047863) |
Baylor Genetics | RCV003470685 | SCV004212143 | uncertain significance | Familial cancer of breast | 2022-12-23 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000553049 | SCV001452134 | uncertain significance | Ataxia-telangiectasia syndrome | 2020-01-24 | no assertion criteria provided | clinical testing |